• Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor

€0.0

round
investor investor

€0.0

round
*

€10.0m

Early VC
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR20182019202020212023
Revenues00000000000000000000
% growth-35 %(22 %)8 %-
EBITDA00000000000000000000
% EBITDA margin-(26 %)(100 %)--
Profit00000000000000000000
% profit margin(1 %)(19 %)(92 %)--
EV00000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x
R&D budget00000000000000000000

Source: Company filings or news article, Dealroom estimates

Notes (0)
More about Deeplink Medical
Made with AI
Edit

Founded in 2014 by five radiologists, including Charles Journé and Vincent Mougenot, Deeplink Medical emerged from the founders' direct experience with cumbersome data management in healthcare. Based in the pharmaceutical hub of Lyon, France, the company aims to streamline medical imaging workflows for healthcare professionals. The business operates on a Software as a Service (SaaS) model, providing its platforms to healthcare establishments and professionals. A significant milestone was a €10 million fundraising round in July 2023, sourced entirely from the medical community, including radiologists and strategic partner IMADIS, France's leading urgent teleradiology group. This followed a €5 million Series A round in December 2019. In late 2023, the company expanded internationally by establishing its first subsidiary in the United States.

Deeplink Medical's core business revolves around developing and deploying web-based platforms that facilitate collaboration and optimize the management of medical imaging data. The client base primarily consists of healthcare centers, hospitals, and clinics, with over 190 partner establishments and more than 31,000 professional users. The company's product suite addresses distinct needs within the radiology and oncology sectors. Its solutions are designed for interoperability with existing hospital information systems like PACS and RIS, adhering to international standards such as HL7 and IHE.

The company's flagship product, ITIS, is a CE-certified Class I medical device platform for managing radiological and teleradiology exams. It structures workflows for both emergency and scheduled exams, allowing healthcare centers to outsource interpretations to partner teleradiology providers or transfer cases within hospital groups to leverage specific expertise. For oncology, Deeplink offers MIRIO, a collaborative platform developed with oncologists and radiologists to standardize the monitoring and evaluation of solid tumors in both clinical trials and routine care. Its third main product, DLMBox, is an image transfer server that ensures the secure and efficient transmission of DICOM-format images between different medical facilities.

Keywords: medical imaging software, teleradiology platform, oncology data management, DICOM image transfer, healthcare workflow optimization, clinical trial imaging, radiological monitoring, patient data management, health-tech, medical SaaS, electronic health records interoperability, PACS integration, RIS integration, Charles Journé, Vincent Mougenot, ITIS, MIRIO, DLMBox, Lyon, French tech

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo